Qube Research & Technologies LTD Co Diagnostics, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CODX
# of Institutions
43Shares Held
5.72MCall Options Held
35.6KPut Options Held
25.9K-
Vanguard Group Inc Valley Forge, PA1.78MShares$533,4540.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$354,4890.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny550KShares$165,0960.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$150,6070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA342KShares$102,6510.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $10.1M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...